ArticleThoracic cancer2020

Efficacy of immune checkpoint inhibitors according to PD-L1 tumor proportion scores in non-small cell lung cancer.

Seongho Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.